Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 275.50%5.13M | 6,467.95%4.97M | -132.72%-923K | -55.86%6.86M | 16.20%7.04M | -181.53%-2.92M | -101.69%-78K | 120.91%2.82M | 510.96%15.55M | 227.47%6.06M |
| Net profit before non-cash adjustment | -5.57%543K | -145.08%-609K | -99.62%3K | -77.37%3.01M | -26.46%303K | 33.10%575K | 437.75%1.35M | -93.93%780K | 6.83%13.3M | -48.56%412K |
| Total adjustment of non-cash items | -10.82%1.69M | -1.73%1.7M | 3.11%1.83M | 202.33%7.99M | 94.81%2.59M | 18.44%1.9M | -1.37%1.73M | 114.18%1.77M | -194.37%-7.81M | -37.22%1.33M |
| -Depreciation and amortization | ---- | ---- | ---- | 2.04%5.75M | ---- | ---- | ---- | ---- | 3.95%5.63M | ---- |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | 1,238.36%831K | ---- | ---- | ---- | ---- | -126.35%-73K | ---- |
| -Disposal profit | ---- | ---- | ---- | 99.99%-1K | ---- | ---- | ---- | ---- | -11,030.28%-15.81M | ---- |
| -Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 9.09%912K | ---- |
| -Other non-cash items | -10.82%1.69M | -1.73%1.7M | 3.11%1.83M | -7.79%1.41M | -137.41%-3.99M | 18.44%1.9M | -1.37%1.73M | 114.18%1.77M | -18.77%1.53M | 349.52%10.66M |
| Changes in working capital | 153.69%2.9M | 222.56%3.87M | -1,119.26%-2.75M | -141.10%-4.13M | -3.91%4.15M | -447.42%-5.39M | -196.61%-3.16M | -70.39%270K | 155.32%10.06M | 156.30%4.32M |
| -Change in receivables | ---- | ---- | ---- | 474.93%6.35M | ---- | ---- | ---- | ---- | 123.88%1.11M | ---- |
| -Change in inventory | ---- | ---- | ---- | -156.13%-10.92M | ---- | ---- | ---- | ---- | 195.73%19.45M | ---- |
| -Change in payables | ---- | ---- | ---- | 104.10%430K | ---- | ---- | ---- | ---- | -255.13%-10.5M | ---- |
| -Changes in other current assets | -22.56%1.6M | 137.37%3.19M | -17.89%3.69M | -121.97%-4.52M | -365.42%-2.55M | -54.95%2.07M | -274.36%-8.53M | -55.59%4.49M | --20.55M | --960K |
| -Changes in other current liabilities | 117.31%1.29M | -87.18%688K | -52.60%-6.44M | 104.09%429K | 100.21%6.75M | -145.22%-7.46M | 431.58%5.37M | 54.13%-4.22M | ---10.49M | --3.37M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 32.89%-51K | 20.00%-64K | -5.19%-81K | 11.89%-326K | -2.20%-93K | 12.64%-76K | 18.37%-80K | 18.09%-77K | -78.74%-370K | -37.88%-91K |
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 95.04%-34K | 1.18%-335K | 58.15%-95K | 50.61%-1.67M | -6,800.00%-414K | -613.54%-685K | 52.25%-339K | 91.13%-227K | 18.36%-3.37M | 99.66%-6K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 236.93%5.04M | 1,019.11%4.57M | -143.66%-1.1M | -58.74%4.87M | 9.59%6.54M | -208.29%-3.68M | -113.01%-497K | 282.92%2.52M | 759.30%11.81M | 190.68%5.96M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 55.47%-224K | 80.77%-189K | -20.81%-209K | 2.19%-2.14M | 64.45%-482K | 97.84%-503K | -104.32%-983K | 35.45%-173K | -168.59%-2.19M | -364.38%-1.36M |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Interest received (cash flow from investment activities) | -15.19%134K | -10.19%141K | -13.25%131K | 7.82%634K | -4.55%168K | -4.82%158K | -20.30%157K | 208.16%151K | 600.00%588K | 147.89%176K |
| Net changes in other investments | ---43K | --0 | --10K | -100.06%-14K | ---- | ---- | ---- | ---- | 28,761.90%24.08M | 81.69%-13K |
| Investing cash flow | 61.45%-133K | 94.19%-48K | -209.09%-68K | -106.77%-1.52M | 72.51%-328K | -82.54%-345K | -6,253.85%-826K | -100.09%-22K | 2,857.67%22.48M | -308.56%-1.19M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -220.27%-2.23M | -150.68%-3.34M | 42.57%2.59M | 67.97%-3.21M | -439.26%-13.48M | 179.99%1.86M | 343.86%6.59M | 172.32%1.82M | -799.91%-10.03M | -764.71%-2.5M |
| Increase or decrease of lease financing | -7.71%-461K | -7.64%-451K | -8.29%-457K | 43.70%-1.75M | -4.77%-483K | -12.93%-428K | -5.81%-419K | 77.51%-422K | 39.85%-3.11M | 65.31%-461K |
| Interest paid (cash flow from financing activities) | 51.92%-263K | 24.94%-316K | 11.92%-340K | 1.66%-1.72M | 15.97%-363K | -33.09%-547K | 8.87%-421K | 12.47%-386K | 0.68%-1.75M | 18.95%-432K |
| Financing cash flow | -435.80%-2.96M | -171.42%-4.11M | 77.72%1.8M | 55.12%-6.68M | -322.23%-14.32M | 128.30%880K | 261.49%5.75M | 120.91%1.01M | -85.06%-14.89M | -63.55%-3.39M |
| Net cash flow | ||||||||||
| Beginning cash position | -38.23%16.51M | -27.83%16.1M | -17.72%15.47M | 3,303.41%18.8M | 35.36%23.59M | 54.33%26.74M | 30.65%22.31M | 3,303.41%18.8M | -105.83%-587K | 108.57%17.43M |
| Current changes in cash | 162.10%1.96M | -90.65%414K | -82.08%628K | -117.18%-3.33M | -688.90%-8.12M | -3,156.31%-3.15M | 1,691.90%4.43M | -80.16%3.51M | 282.02%19.39M | 115.41%1.38M |
| End cash Position | -21.70%18.47M | -38.23%16.51M | -27.83%16.1M | -17.72%15.47M | -17.72%15.47M | 35.36%23.59M | 54.33%26.74M | 30.65%22.31M | 3,303.41%18.8M | 3,303.41%18.8M |
| Free cash flow | 215.03%4.82M | 395.68%4.38M | -155.80%-1.31M | -71.54%2.73M | 31.42%6.05M | -238.43%-4.19M | -141.00%-1.48M | 242.58%2.34M | 451.76%9.6M | 167.20%4.61M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.